Black Friday Sale: 20% off everything. Ends Tuesday 1 December, 11:59 pm AEDT.
For laboratory and research use only. Not for human consumption.  Sold exclusively to qualified researchers and licensed laboratories.

CATALOGUE  /  NAD+

NAD+ 100MG

NAD+, lyophilised powder in a sealed vial

NAD+

Research reagent · Powder in a sealed vial · for laboratory and research use only

NAD+ 100mg Quantity per vial: 100mg
$99.95$79.96
Secure card payments
Not a drug, food or cosmetic. For laboratory and research use only. Not for human consumption. This product has not been evaluated or approved by the US Food and Drug Administration (FDA) or the Australian Therapeutic Goods Administration (TGA), and it is not intended to diagnose, treat, cure or prevent any disease. Sold exclusively to qualified researchers and licensed laboratories.

Reagent specifications

CAS number53-84-9
Molecular weight663.43 g/mol (PubChem reference value)
StorageSealed, dry and dark at −20 °C or colder; warm to room temperature in a desiccator before opening
Certificate of analysisAvailable on request · Request a COA

CAS number and molecular weight are reference values for the compound identity, from PubChem.

Compound identity

Compound classDinucleotide coenzyme (small molecule)
Full nameNicotinamide adenine dinucleotide (oxidised form)
Molecular formulaC21H27N7O14P2 (PubChem)
PubChem CID5893
Supplied asPowder, sealed vial
Quantity per vial100 mg
Intended useLaboratory and research use only

About NAD+

NAD+ is nicotinamide adenine dinucleotide, the oxidised form of a dinucleotide coenzyme made of two nucleotides joined through their phosphate groups, one carrying an adenine base and the other a nicotinamide base.1 It is a small molecule, not a peptide, and it is a standard substrate in biochemical assays, where its reduced counterpart NADH is the other half of the redox pair.

Titan Peptides supplies NAD+ as a powder in a sealed 100 mg vial, for laboratory and research use only. It is a research chemical: not a drug, food or cosmetic, and not for human consumption.

Status in Australia

Australia's June 2026 Poisons Standard (F2026L00633) is the legal reference for scheduled substances; check it, and any later amendment, for the current position of any compound you intend to hold.2 No product sold by Titan Peptides is an approved therapeutic good, and the research-grade material sold here is not one. How a product is supplied and presented also shapes its legal position; our guide to research peptides and Australian law sets out the framework.

Laboratory handling & storage

NAD+ is hygroscopic and sensitive to moisture, so keep the vial sealed, dry, dark and frozen, and warm it to room temperature inside a desiccator before opening so no condensation forms on the powder. In solution the molecule is far less stable than as a solid, and its stability depends on pH and temperature: it degrades faster in alkaline or warm solutions. Prepare solutions fresh where possible, or split a stock into single-use aliquots, freeze them and do not refreeze a thawed tube. More on storing lyophilised and reconstituted material and choosing a diluent.

NAD+ quick answers

What form is NAD+ supplied in?

NAD+ is supplied as a powder in a sealed vial containing 100 mg, for laboratory and research use only. It is a research chemical, not a drug, food or cosmetic, and is not for human consumption.

What is the CAS number of NAD+?

PubChem lists NAD+ (nicotinamide adenine dinucleotide) under CAS number 53-84-9 and CID 5893, with the molecular formula C21H27N7O14P2 and a molar mass of 663.43 g/mol. These identifiers let you match a vial, its documentation and the published literature to the same molecule.

Is a certificate of analysis available for NAD+?

A certificate for a specific batch is available on request. No purity figure is published on this page until a verified certificate has been supplied.

References

  1. PubChem. NAD+ (nicotinamide adenine dinucleotide), CID 5893. National Center for Biotechnology Information. Source
  2. Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 (Standard for the Uniform Scheduling of Medicines and Poisons No. 48), F2026L00633. Commenced 1 June 2026. Federal Register of Legislation. Source
Research use only. Not a drug, food or cosmetic. NAD+ is supplied strictly for laboratory and in-vitro research and is not for human consumption. It is not an approved therapeutic good in Australia, has not been evaluated or approved by the FDA or the TGA, and is not intended to diagnose, treat, cure or prevent any disease. Titan Peptides sells exclusively to qualified researchers and licensed laboratories.